Effects of losartan in patients with NAFLD: A meta-analysis of randomized controlled trial

Losartan has become a hot spot in the treatment of non-alcoholic fatty liver disease (NAFLD) among angiotensin receptor blocker drugs. We sought to conduct a systematic examination and meta-analysis to examine the effects of losartan on patients with NAFLD. We searched for potentially randomized con...

Descripción completa

Detalles Bibliográficos
Autores principales: Meng, Chang, Song, Zejun, Zhang, Lingnan, Geng, Yu, Sun, Jing, Miao, Guobin, Liu, Peng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: De Gruyter 2023
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10031500/
https://www.ncbi.nlm.nih.gov/pubmed/36970603
http://dx.doi.org/10.1515/biol-2022-0583

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10031500/
https://www.ncbi.nlm.nih.gov/pubmed/36970603
http://dx.doi.org/10.1515/biol-2022-0583

Ejemplares similares